Recruitment commenced in first study of TRPV1 Inhibitor in COPD Cough• Randomised, double-blind, placebo-controlled, cross-over Phase IIa trial • Short duration study, expected to complete Q3, 2014• Professor Maria Belvisi appointed Chief Scientific Officer
26 February, 2014
Panama has now approved the next phase of evaluation for Oxitec's sterile mosquitoes as a novel tool to combat the dengue mosquito.
01 February, 2014